Persistent long term benefits achieved from hyperbaric oxygen therapy in post COVID condition:

The Researchers of this study previously documented that Hyperbaric Oxygen therapy (HBOT) was able to help provide “significant improvements in cognitive, psychiatric, fatigue, sleep, and pain symptoms” for those individuals suffering from Long COVID syndrome (LCS)

In this follow up study, researchers wanted to determine if the reported benefits were long-lasting, so they required a full 40 hour couses of HBOT along with a one-year minimum follow up evaluation for all participants.

The follow up results confirmed that alll the clinical improvements gained by HBOT were persistent even 1 year after the last HBOT session”<view study>